Synthesis and biological evaluation of atropisomeric tetrahydroisoquinolines overcoming docetaxel resistance in triple-negative human breast cancer cells
- Authors
- Song, J.[Song, Jayoung]; Kim, A.[Kim, Ahreum]; Hong, I.[Hong, Intaek]; Kim, S.[Kim, Sangji]; Byun, W.S.[Byun, Woong Sub]; Lee, H.S.[Lee, Hyun Soo]; Kim, H.S.[Kim, Hyung Sik]; Lee, S.K.[Lee, Sang Kook]; Kwon, Y.[Kwon, Yongseok]
- Issue Date
- 1-Aug-2023
- Publisher
- Academic Press Inc.
- Keywords
- Apoptosis; Atropisomerism; Docetaxel resistance; Isoquinolines; STAT3; Triple-negative breast cancer
- Citation
- Bioorganic Chemistry, v.137
- Indexed
- SCIE
SCOPUS
- Journal Title
- Bioorganic Chemistry
- Volume
- 137
- URI
- https://scholarworks.bwise.kr/skku/handle/2021.sw.skku/106248
- DOI
- 10.1016/j.bioorg.2023.106573
- ISSN
- 0045-2068
- Abstract
- Herein, atropisomeric 8-aryltetrahydroisoquinolines have been synthesized and biologically evaluated. Based on our structure–activity relationship study, a highly bioactive racemic compound has been produced, and it exhibited high antiproliferative activities against various cancer cell lines, including docetaxel-resistant breast cancer cell lines. Each enantiomer can be synthesized in an enantioselective manner by employing the chiral phosphoric acid-catalyzed atroposelective Pictet–Spengler cyclization. An axially (R)-configured enantiomer showed a higher biological activity compared with the axially (S)-configured enantiomer. Further biological studies suggested that the (R)-enantiomer overcomes docetaxel resistance via the downregulation of signal transducer and activator of transcription 3 activation and consequently induces cellular apoptosis in docetaxel-resistant triple-negative breast cancer cell lines. © 2023 Elsevier Inc.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Pharmacy > Department of Pharmacy > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.